missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Doxorubicin Hydrochlorid, LoGiCal
Tekniske data
Tekniske data
| Kemisk navn eller materiale | Doxorubicin Hydrochloride |
| CAS | 25316-40-9 |
| Analyt- eller komponentnavne | Doxorubicin Hydrochloride |
| Forsendelsestilstand | Stuetemperatur |
| Molekylær formel | C27 H29 N O11 . Cl H |
| Certificeringer/compliance | ISO 9001 |
| Synonym | Daunorubicin Hydrochloride Imp. D (EP), Daunorubicin Imp. D (EP), Epirubicin Hydrochloride Imp. C (EP), Epirubicin Imp. C (EP), 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-, Adriamycin, hydrochloride, ADM hydrochloride, ADR, Adriablastina CS, Adriacin, Adriamycin, Adriblastin, Adriblastina, Adriblastina RD, DOX HCl, Doxorubicin Hydrochloride, FI 106, FI 6804, Hydroxydaunorubicin hydrochloride, Lipo-Dox, Daunorubicin Hydrochloride Impurity D as Hydrochloride, Epirubicin Hydrochloride Impurity C as Hydrochloride, Daunorubicin Impurity D as Hydrochloride, Epirubicin Impurity C as Hydrochloride |
| InChI formel | InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1 |
| Løsningstype | Fedt |
| SMIL | Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO |
| Vis mere |
Produkttitel
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?